Skip to main content

Table 5 Comparison between the three groups according to Troponin-T

From: Cardioprotective effect of propofol in cardioplegia compared to systemic propofol in heart valves surgery; a randomized controlled trial

Troponin-T (pg/ml)

Group 1 (n = 50)

Group 2 (n = 50)

Group 3 (n = 50)

p

Pre-operative

 Range

2.47 – 31.60

0.90 – 14.0

0.90 – 10.0

 

 Mean ± SD

7.42 ± 4.41

6.55 ± 3.01

5.87 ± 2.30

0.072

After 1 h

 Range

412.0 – 4391.0

417.0 – 1430.0

412.0 – 1553.0

 

 Mean ± SD

905.9 ± 552.1

894.5 ± 212.2

879.3 ± 249.7

 

 Mean effect size

898.47 ± 552.27

887.99 ± 211.83

873.47 ± 249.68

0.944

After 12 h

 Range

385.0 – 4138.0

305.0 – 1380.0

360.0 – 1300.0

 

 Mean ± SD

797.4 ± 518.6

741.7 ± 228.1

786.4 ± 222.9

 

 Mean effect size

789.93 ± 518.74

735.19 ± 227.66

780.49 ± 222.92

0.708

After 1 day

 Range

126.0 – 2178.0

104.0 – 992.0

280.0 – 900.0

 

 Mean ± SD

449.9 ± 289.3

368.90 ± 239.56

501.9 ± 152.7

 

 Mean effect size

442.49 ± 289.80

362.35 ± 240.39

496.03 ± 152.56

0.018*

Significance between groups

p1 = 0.257, p2 = 0.806, p3 = 0.015*

 

After 3 days

 Range

76.0 – 870.0

50.0 – 710.0

140.0 – 790.0

 

 Mean ± SD

246.4 ± 131.4

202.54 ± 156.03

317.0 ± 117.9

 

 Mean effect size

238.96 ± 132.13

195.99 ± 156.31

311.09 ± 117.69

 < 0.001*

Significance between groups

p1 = 0.328, p2 = 0.031*, p3 < 0.001*

 

F

40.781

464.261

182.196

 

p

 < 0.001*

 < 0.001*

 < 0.001*

 
  1. Data are presented as range, mean ± SD. and mean effect size. P1: p value for comparing between group1 and group2, P2: p value for comparing between group1 and group3, P3: p value for comparing between group2 and group3 * P < 0.05 is statistically significant
  2. Group 1: Patients with propofol in the cardioplegia, Group 2: Patients with propofol injection in the aortic line, Group 3 (control group): Patients without propofol in the cardioplegia or aortic line